Supply of Doxycycline Hyclate Tablets (NSN 6505016421190)

The contract involves the manufacture and supply of FDA-approved Doxycycline Hyclate 100 mg tablets in bulk packaging, specifically designated for delivery to a U.S. Navy vessel under the National Stock Number 6505016421190. The product must meet stringent military and federal pharmaceutical standards, ensuring full compliance with quality, safety, and documentation requirements for federal procurement. The supplier is expected to adhere to all applicable regulations governing pharmaceutical production and bulk distribution to support Department of Defense operational needs. The contract is issued under the Defense Logistics Agency as part of the Department of Defense procurement system, with the NAICS code 325412 indicating classification within pharmaceutical and medicine manufacturing. While no solicitation number is provided, the contract is identified through the award number SPE2DX25D8022 and delivery order SPE2D926F7852. The place of performance and point of contact details are not specified, but the work is tied to military logistics channels, and the contract was posted on August 2, 2026, as a subcontract. All delivered units must be traceable, properly labeled, and packaged to meet DoD inventory and deployment protocols for medical readiness on naval platforms.